Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-266706
Filing Date
2021-09-07
Accepted
2021-09-07 16:55:02
Documents
5
Period of Report
2021-09-07

Document Format Files

Seq Description Document Type Size
1 6-K d224028d6k.htm 6-K 17233
2 EX-1.1 d224028dex11.htm EX-1.1 233083
3 EX-3.1 d224028dex31.htm EX-3.1 373080
4 EX-5.1 d224028dex51.htm EX-5.1 30687
5 GRAPHIC g224028g0904031116205.jpg GRAPHIC 2512
  Complete submission text file 0001193125-21-266706.txt   658679
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 211239864
SIC: 2834 Pharmaceutical Preparations